Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer
Harter, Philipp, Sehouli, Jalid, Vergote, Ignace, Ferron, Gwenael, Reuss, Alexander, Meier, Werner, Greggi, Stefano, Mosgard, Berit J, Selle, Frederic, Guyon, Frédéric, Pomel, Christophe, Lécuru, Fabrice, Zang, Rongyu, Avall-Lundqvist, Elisabeth, Kim, Jae-Weon, Ponce, Jordi, Raspagliesi, Francesco, Kristensen, Gunnar, Classe, Jean-Marc, Hillemanns, Peter, Jensen, Pernille, Hasenburg, Annette, Ghaem-Maghami, Sadaf, Mirza, Mansoor R, Lund, Bente, Reinthaller, Alexander, Santaballa, Ana, Olaitan, Adeola, Hilpert, Felix, du Bois, Andreas
Published in The New England journal of medicine (02.12.2021)
Published in The New England journal of medicine (02.12.2021)
Get full text
Journal Article
Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors
McGee, J., Bookman, M., Harter, P., Marth, C., McNeish, I., Moore, K.N., Poveda, A., Hilpert, F., Hasegawa, K., Bacon, M., Gatsonis, C., Brand, A., Kridelka, F., Berek, J., Ottevanger, N., Levy, T., Silverberg, S., Kim, B.-G., Hirte, H., Okamoto, A., Stuart, G., Ochiai, K.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
Conference Proceeding
Web Resource
Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy
Roncolato, F.T., Gibbs, E., Lee, C.K., Asher, R., Davies, L.C., Gebski, V.J., Friedlander, M., Hilpert, F., Wenzel, L., Stockler, M.R., King, M., Pujade-Lauraine, E.
Published in Annals of oncology (01.08.2017)
Published in Annals of oncology (01.08.2017)
Get full text
Journal Article
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters—patient-centered end points in trials of maintenance therapy
Friedlander, M., Rau, J., Lee, C.K., Meier, W., Lesoin, A., Kim, J.-W., Poveda, A., Buck, M., Scambia, G., Shimada, M., Hilpert, F., King, M.T., Debruyne, P., Bologna, A., Malander, S., Monk, B.J., Petru, E., Calvert, P., Herzog, T.J., Barrett, C., du Bois, A.
Published in Annals of oncology (01.03.2018)
Published in Annals of oncology (01.03.2018)
Get full text
Journal Article
Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial
Trillsch, F., Mahner, S., Hilpert, F., Davies, L., García-Martínez, E., Kristensen, G., Savarese, A., Vuylsteke, P., Los, M., Zagouri, F., Gladieff, L., Sehouli, J., Khoon Lee, C., Gebski, V., Pujade-Lauraine, E.
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article
Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial
Lindemann, K., Kristensen, G., Mirza, M.R., Davies, L., Hilpert, F., Romero, I., Ayhan, A., Burges, A., Rubio, M.J., Raspagliesi, F., Huizing, M., Creemers, G.-J., Lykka, M., Lee, C.K., Gebski, V., Pujade-Lauraine, E.
Published in Annals of oncology (01.08.2016)
Published in Annals of oncology (01.08.2016)
Get full text
Journal Article
An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans
Griel, Amy E, Kris-Etherton, Penny M, Hilpert, Kirsten F, Zhao, Guixiang, West, Sheila G, Corwin, Rebecca L
Published in Nutrition journal (16.01.2007)
Published in Nutrition journal (16.01.2007)
Get full text
Journal Article
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study
Trillsch, F., Mahner, S., Woelber, L., Vettorazzi, E., Reuss, A., Ewald-Riegler, N., de Gregorio, N., Fotopoulou, C., Schmalfeldt, B., Burges, A., Hilpert, F., Fehm, T., Meier, W., Hillemanns, P., Hanker, L., Hasenburg, A., Strauss, H.G., Hellriegel, M., Wimberger, P., Baumann, K., Keyver-Paik, M.D., Canzler, U., Wollschlaeger, K., Forner, D., Pfisterer, J., Schroeder, W., Muenstedt, K., Richter, B., Kommoss, F., Hauptmann, S., du Bois, A.
Published in Annals of oncology (01.07.2014)
Published in Annals of oncology (01.07.2014)
Get full text
Journal Article
Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO
Klar, M, Hasenburg, A, Hasanov, M, Hilpert, F, Meier, W, Pfisterer, J, Pujade-Lauraine, E, Herrstedt, J, Reuss, A, du Bois, A
Published in European journal of cancer (1990) (01.10.2016)
Published in European journal of cancer (1990) (01.10.2016)
Get full text
Journal Article
A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy
Baumann, K.H., du Bois, A., Meier, W., Rau, J., Wimberger, P., Sehouli, J., Kurzeder, C., Hilpert, F., Hasenburg, A., Canzler, U., Hanker, L.C., Hillemanns, P., Richter, B., Wollschlaeger, K., Dewitz, T., Bauerschlag, D., Wagner, U.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Neoadjuvant chemotherapy in ovarian cancer revisited
Mahner, S, Trillsch, F, Chi, D, Harter, P, Pfisterer, J, Hilpert, F, Burges, A, Weissenbacher, T, du Bois, A
Published in Annals of oncology (01.04.2016)
Published in Annals of oncology (01.04.2016)
Get full text
Journal Article
Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR)
Sehouli, J., Chekerov, R., Reinthaller, A., Richter, R., Gonzalez-Martin, A., Harter, P., Woopen, H., Petru, E., Hanker, L.C., Keil, E., Wimberger, P., Klare, P., Kurzeder, C., Hilpert, F., Belau, A.K., Zeimet, A., Bover-Barcelo, I., Canzler, U., Mahner, S., Meier, W.
Published in Annals of oncology (01.12.2016)
Published in Annals of oncology (01.12.2016)
Get full text
Journal Article
Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, fallopian or peritoneal carcinoma (the NOGGO-AGO QoL Prognosis-Score-Study): results of a meta-analysis in 2209 patients
Armbrust, R., Richter, R., Woopen, H., Hilpert, F., Harter, P., Sehouli, J.
Published in ESMO open (01.04.2021)
Published in ESMO open (01.04.2021)
Get full text
Journal Article
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)
Roncolato, F.T., O'Connell, R.L., Joly, F., Lanceley, A., Hilpert, F., Buizen, L., Okamoto, A., Aotani, E., Salutari, V., Donnellan, P., Oza, A., Avall-Lundqvist, E., Berek, J., Fehm, T., Ledermann, J., Roemer-Becuwe, C., Stockler, M.R., King, M.T., Friedlander, M.L.
Published in Gynecologic oncology (01.01.2020)
Published in Gynecologic oncology (01.01.2020)
Get full text
Journal Article
Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer
Kris-Etherton, Penny M, Hecker, Kari D, Bonanome, Andrea, Coval, Stacie M, Binkoski, Amy E, Hilpert, Kirsten F, Griel, Amy E, Etherton, Terry D
Published in The American journal of medicine (30.12.2002)
Published in The American journal of medicine (30.12.2002)
Get full text
Journal Article
Corrigendum to ‘Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, fallopian or peritoneal carcinoma (the NOGGO-AGO QoL Prognosis-Score-Study): results of a meta-analysis in 2209 patients’: [ESMO Open Volume 6, Issue 2, April 2021, 100081]
Richter, R., Armbrust, R., Woopen, H., Hilpert, F., Harter, P., Sehouli, J.
Published in ESMO open (01.08.2021)
Published in ESMO open (01.08.2021)
Get full text
Journal Article
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study
Trillsch, F, Mahner, S, Vettorazzi, E, Woelber, L, Reuss, A, Baumann, K, Keyver-Paik, M-D, Canzler, U, Wollschlaeger, K, Forner, D, Pfisterer, J, Schroeder, W, Muenstedt, K, Richter, B, Fotopoulou, C, Schmalfeldt, B, Burges, A, Ewald-Riegler, N, de Gregorio, N, Hilpert, F, Fehm, T, Meier, W, Hillemanns, P, Hanker, L, Hasenburg, A, Strauss, H-G, Hellriegel, M, Wimberger, P, Kommoss, S, Kommoss, F, Hauptmann, S, du Bois, A
Published in British journal of cancer (17.02.2015)
Published in British journal of cancer (17.02.2015)
Get full text
Journal Article
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged ≥70 years with advanced ovarian cancer—a study by the AGO OVAR Germany
Hilpert, F., du Bois, A., Greimel, E.R., Hedderich, J., Krause, G., Venhoff, L., Loibl, S., Pfisterer, J.
Published in Annals of oncology (01.02.2007)
Published in Annals of oncology (01.02.2007)
Get full text
Journal Article
34LBA Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: A multinational randomised, placebo-controlled, double-blind trial – the GAND-emesis study
Ruhlmann, C.H, Christensen, T.B, Dohn, L.H, Paludan, M, Rannengart, E, Hilpert, F, Feyer, P, Kristensen, G, Keefe, D, Hansen, O, Herrstedt, J
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article